Masimo Corp
MASI139.150USD
+3.820+2.82%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
7.39BCap. mercado
PérdidaP/E TTM
Más Datos de Masimo Corp Compañía
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Información de Masimo Corp
Símbolo de cotizaciónMASI
Nombre de la empresaMasimo Corp
Fecha de salida a bolsaAug 08, 2007
Director ejecutivoSzyman (Catherine M)
Número de empleados3600
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección52 Discovery
CiudadIRVINE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92618
Teléfono19492977000
Sitio Webhttps://www.masimo.com/
Símbolo de cotizaciónMASI
Fecha de salida a bolsaAug 08, 2007
Director ejecutivoSzyman (Catherine M)
Ejecutivos de Masimo Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+6922.00%
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Tim Benner
Mr. Tim Benner
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
15.54K
+6922.00%
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2024
FY2023
FY2022
FY2022Q1
FY2021
FY2020
FY2019
FY2018
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.13B
53.84%
Europe, Middle East and Africa
595.60M
28.44%
Asia and Australia
303.50M
14.49%
North and South America (excluding the U.S.)
67.70M
3.23%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 30 de nov
Actualizado: dom., 30 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.88%
Politan Capital Management, L.P.
8.54%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
8.02%
BlackRock Investment Management (UK) Ltd.
5.61%
Otro
56.87%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.88%
Politan Capital Management, L.P.
8.54%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
8.02%
BlackRock Investment Management (UK) Ltd.
5.61%
Otro
56.87%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
54.68%
Investment Advisor/Hedge Fund
32.53%
Hedge Fund
13.45%
Individual Investor
5.75%
Research Firm
3.52%
Pension Fund
1.04%
Bank and Trust
0.39%
Venture Capital
0.18%
Sovereign Wealth Fund
0.14%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
834
56.90M
105.94%
-6.08M
2025Q3
847
60.04M
111.77%
-4.36M
2025Q2
937
59.97M
110.39%
-7.53M
2025Q1
981
59.62M
109.96%
-8.22M
2024Q4
950
56.99M
105.70%
-7.11M
2024Q3
945
55.24M
103.11%
-8.43M
2024Q2
962
54.27M
102.01%
-12.67M
2024Q1
1002
56.30M
106.05%
-9.64M
2023Q4
1090
55.26M
104.56%
-6.33M
2023Q3
1093
52.14M
98.67%
-6.57M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
6.92M
12.88%
-25.87K
-0.37%
Sep 30, 2025
Politan Capital Management, L.P.
4.59M
8.54%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
4.80M
8.93%
+171.32K
+3.70%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.31M
8.02%
+70.24K
+1.66%
Sep 30, 2025
BlackRock Investment Management (UK) Ltd.
3.02M
5.61%
-61.18K
-1.99%
Sep 30, 2025
Kiani (Joe E)
2.87M
5.34%
-245.80K
-7.90%
Sep 30, 2025
MFS Investment Management
2.61M
4.87%
+149.74K
+6.07%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.13M
3.96%
-373.38K
-14.93%
Sep 30, 2025
Capital Research Global Investors
1.85M
3.45%
-1.54K
-0.08%
Sep 30, 2025
BlackRock Financial Management, Inc.
1.61M
3%
-224.33K
-12.22%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Harbor Health Care ETF
4.85%
iShares US Select Equity Active ETF
3.53%
Global X HealthTech ETF
3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.63%
First Trust Indxx Medical Devices ETF
1.95%
State Street SPDR S&P Health Care Equipment ETF
1.72%
Langar Global HealthTech ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.27%
Tema Heart & Health ETF
1.24%
Invesco S&P MidCap 400 Pure Growth ETF
1.18%
Ver más
Harbor Health Care ETF
Proporción4.85%
iShares US Select Equity Active ETF
Proporción3.53%
Global X HealthTech ETF
Proporción3.3%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción2.63%
First Trust Indxx Medical Devices ETF
Proporción1.95%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.72%
Langar Global HealthTech ETF
Proporción1.72%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.27%
Tema Heart & Health ETF
Proporción1.24%
Invesco S&P MidCap 400 Pure Growth ETF
Proporción1.18%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
